Matthew Autterson is undeniably one of the most experienced executives in the finance service segment. He spent about 25 years of his career in the industry where he served as the president one of the country’s largest state chartered financial companies. Currently, Matthew serves as the chief executive officer, president and board member of CNS Bioscience, Inc. Founded by Scott Falci in 2013, CNS prides itself on being a clinical-stage drug development company that focuses on neuropathic pain.
Aside from being knowledgeable and experienced in matters regarding the finance industry, Matthew Autterson is a well-educated individual. He is an alumnus of the Michigan Stet University where he graduated in 1980 with a B.A. in Finance. Matthews’s thirst for education did not end there as he later participated in the University of Denver Graduate Tax Program.
Matthew Autterson embarked on his career by joining the First Trust Corporation, which is a subsidiary firm of Fiserv. Later in 1982, he left the company in a bid to join a small team that aimed at chartering a new Colorado State chartered trust company to operate as a subsidiary of Integrated Resources, Inc., a New York-based financial services institution. In 1986, Matthew Autterson assumed the president’s role at Resources Trust Company. Broad Inc. acquired Resources Trust Company among other Integrated Resources-owned assets in 1989. Subsequently, it changed its name from Broad Inc. to SunAmerica, Inc., which AIG later acquired in 1988 for a whopping $18 million.
In 2001, Fiserv acquired Resources Trust Company from AIG. Before the completion of the sale, Resources Trust Company had a reputation for being the largest FDIC-insured depository fund and state-chartered companies nationwide. In fact, the company provided both custodial and depository services to over 200,000 customers who were brought to the company through its more than 15,000 registered independent financial advisors. With about 700 employees, Resources Trust Company also held over $1 billion in deposits and $20 billion in custodial assets.
Matthew Autterson is a member of various boards such as the Board of Directors of Falci Adaptive Biosystems (FAB), which is a dominant body in Colorado’s business community. FAB represents Matthew Autterson’s present philanthropic interests following his many years of leadership functions with the Denver Zoological Foundation, Board of Denver Zoo, and the Webb-Waring Foundation. He holds the chairperson’s position on the Board of Directors of Denver Hospice. Formerly, he was a member of the World Presidents Organization and the Young Presidents Organization.